GLP-1 Program Comparison Table: 12 Criteria That Actually Matter

Why a table beats ad-hoc comparison

Without a structured table, most buyers overweight first-month price and underweight continuity risks. This often leads to avoidable switching, delays, and dissatisfaction.

A stable scoring framework makes your decision process reproducible and less vulnerable to urgency or marketing framing.

Sources: [1] [2] [4]

The 12 criteria to score

• First-90-day total cost clarity
• Policy clarity for cancel, pause, and restart
• Refill and shipment continuity process
• Support response-time standards
• Clinical review and escalation pathway
• Evidence quality behind claims
• Transparency of contraindications and risk language
• Verification of prescriber/pharmacy pathway
• Incident replacement process
• Disclosure quality for promotions and affiliates
• Consistency of policy language across pages
• Post-purchase communication quality

Sources: [1] [3] [5]

Suggested weighting model

This model intentionally prioritizes continuity and reliability because these factors drive real-world treatment stability more than short-term promotional pricing.

• Continuity and policy reliability: 40%
• Cost clarity and predictability: 25%
• Clinical/process transparency: 20%
• Claim/disclosure discipline: 15%

Sources: [2] [4] [6]

Decision thresholds

A threshold approach prevents checkout decisions when core process information is incomplete.

• 22-25: strong operational fit
• 18-21: usable with targeted clarifications
• Below 18: unresolved risk, continue comparing

Sources: [1] [3] [5]

Bottom line

The best comparison table is one you can reuse across every option in your shortlist.

A disciplined scorecard reduces noise, protects budget decisions, and improves the chance you choose a program you can sustain.

Sources: [1] [2] [3]